Advancing Biosimilar Adoption: The Michigan Experience
As health care costs continue to rise across the United States, employers, patients and health plans are looking for ways to address the escalating cost of prescription drugs. Biosimilar adoption has emerged as one strategy to contain costs and expand access to life saving therapies. Join us for a discussion of biosimilar substitution strategies employed by health plans and employer groups within Michigan, including:
- Strategies for advancing biosimilar adoption
- Common barriers to biosimilar adoption
- Recommendations for developing a successful biosimilar program
Executive Director, The Biosimilars Forum
Bret Jackson is the president of the non-profit Economic Alliance for Michigan (EAM). EAM is comprised of businesses and unions working together with one clear objective, the continued growth of Michigan’s economy by creating an atmosphere that inspires job growth and maintains Michigan’s competitiveness for attracting new companies and talent.
This webinar is sponsored, developed and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.
For individuals from the media/press who are interested in attending, please email firstname.lastname@example.org.